This is the quote from Biomerieux half yearly discussing the partnership with Philips and Magnotech :
"Partnership with Philips in automated Point-of-Care
In January 2010, Philips and bioMérieux began collaborating to jointly develop fully automated handheld diagnostic testing solutions for hospital use that can be deployed at the point-of-care – i.e. close to the patient.
Given the challenges encountered in developing Troponin solutions delivering performance comparable to central laboratory analyzers, both partners have signed an addendum to the original agreement.
It provides that Philips will separately pursue development of the Troponin assay and system. bioMérieux will discontinue its own assay development during this development period, but provide an undisclosed level of funding toward the development. In addition, this addendum maintains bioMérieux’s rights to re-engage on a non-exclusive basis, until March 31, 2014."
If POC1 is Philips then i would say it is GO TIME!
- Forums
- ASX - By Stock
- ADO
- predictions for end of 2014
predictions for end of 2014, page-11
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ADO (ASX) to my watchlist
|
|||||
Last
2.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $51.83M |
Open | High | Low | Value | Volume |
2.1¢ | 2.2¢ | 2.1¢ | $3.414K | 161.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 384663 | 2.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.2¢ | 616353 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 384663 | 0.021 |
12 | 2157550 | 0.020 |
10 | 3040767 | 0.019 |
10 | 1652665 | 0.018 |
3 | 94160 | 0.017 |
Price($) | Vol. | No. |
---|---|---|
0.022 | 616353 | 6 |
0.023 | 857853 | 5 |
0.024 | 1306228 | 3 |
0.025 | 214144 | 4 |
0.027 | 680612 | 2 |
Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
Featured News
TLX
Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
FWD
Queensland's housing crisis an opportunity for ASX builder Fleetwood – and taxpayer cash a safe harbour from the storm
ADO (ASX) Chart |